FDA slaps gene therapy Elevidys with boxed warning after fatal liver failures
Elevidys came under scrutiny in June when the FDA disclosed two fatal cases in non-ambulatory boys who developed dangerously high liver enzyme levels
Elevidys came under scrutiny in June when the FDA disclosed two fatal cases in non-ambulatory boys who developed dangerously high liver enzyme levels
Adzynma, approved for both adults and children with cTTP, is a recombinant enzyme therapy designed to replace the deficient ADAMTS13 enzyme
Glucagon-Like Peptide-1 is a natural hormone that regulates blood sugar, controls appetite, and slows digestion
This move positions the U.S.-based consumer healthcare company for a significantly larger role in the rapidly expanding at-home and retail diagnostic testing market
The FW500 is designed to meet the evolving needs of mid-sized diagnostic laboratories
Revenues up 13.1% year-over-year; Continued momentum driven by organic growth, strategic partnerships, and acquisitions
Breakthrough expands proactive TB screening from birth to 15 years, ensuring faster and more accurate diagnosis
BIL also holds an option to increase its equity stake by an additional 15%
The Phase Ib MAD study is a randomized, double-blind, placebo-controlled trial conducted in the United States
Subscribe To Our Newsletter & Stay Updated